Sabby Management’s Genocea Biosciences, Inc. GNCA Stock Holding History

Sabby Management’s Portfolio GNCA Stock Details GNCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-312,666	Closed	-$716K	–	170
2020 Q3	$716K	Buy	312,666 +187,354	+150%	+$492K	0.11%	72
2020 Q2	$288K	Sell	125,312 -314,962	-72%	-$725K	0.06%	70
2020 Q1	$757K	Sell	440,274 -98,085	-18%	-$198K	0.31%	30
2019 Q4	$1.11M	Buy	538,359 +61,008	+13%	+$145K	0.31%	17
2019 Q3	$1.38M	Sell	477,351 -16,824	-3%	-$57.4K	0.75%	16
2019 Q2	$1.94M	Buy	+494,175	New	+$2.58M	2.44%	9
2016 Q1	–	Sell	-19,517	Closed	-$823K	–	382
2015 Q4	$823K	Sell	19,517 -71,626	-79%	-$3.41M	0.05%	205
2015 Q3	$5M	Buy	91,143 +70,070	+333%	+$6.95M	0.21%	83
2015 Q2	$2.31M	Buy	21,073 +8,573	+69%	+$796K	0.08%	152
2015 Q1	$1.19M	Buy	+12,500	New	+$882K	0.05%	179

Other funds holding GNCA

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sabby Management's GNCA Position: Q4 2020 in Review

Sabby Management sold out of Genocea Biosciences, Inc. (GNCA) in Q4 2020, closing a stake of 312,666 shares — an estimated $716K sold.

Sabby Management first reported a position in GNCA in Q1 2015 and held it in 10 quarters. The position peaked at $5M in Q3 2015. 39 funds tracked by Wall St. Rank hold GNCA as of Q4 2020.

Sabby Management reported no remaining Genocea Biosciences, Inc. position as of Q4 2020 after selling out during the quarter.
Sabby Management sold 312,666 Genocea Biosciences, Inc. shares in Q4 2020, an estimated $716K.
Sabby Management first reported a position in Genocea Biosciences, Inc. in Q1 2015 and held it in 10 quarters.
Sabby Management's Genocea Biosciences, Inc. position peaked at $5M in Q3 2015.
39 funds tracked by Wall St. Rank held Genocea Biosciences, Inc. as of Q4 2020.

Based on Sabby Management's 13F filing for Q4 2020, filed 16 Feb 2021.